{"id":"W4387809545","doi":"10.1016/j.annonc.2023.10.060","title":"LBA5 Amivantamab plus chemotherapy vs chemotherapy as first-line treatment in EGFR Exon 20 insertion-mutated advanced non-small cell lung cancer (NSCLC): Primary results from PAPILLON, a randomized phase III global study","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Chemotherapy; Oncology; Lung cancer; Exon; Internal medicine; non-small cell lung cancer (NSCLC); Gene; A549 cell; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009683135,0.001105671,0.002379532,0.0004523088,0.0002468202,0.0009529568,0.0007767599,0.001008369,0.004342972],"category_scores_gemma":[0.000718974,0.0004081898,0.002024089,0.0004687229,0.000792051,0.0008788254,0.0003652833,0.002160428,0.0006496276],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001121104,"about_ca_system_score_gemma":0.0009829145,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00203067,"about_ca_topic_score_gemma":0.005853243,"domain_scores_codex":[0.9996322,0.0001773717,0.00001592202,0.00006420345,0.00002687732,0.00008331395],"domain_scores_gemma":[0.999549,0.0001347955,0.0001017809,0.00002618868,0.00001907605,0.0001692038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.946202,0.005496432,0.001394583,0.0006087216,0.001917348,0.00003339681,0.00004948133,0.0008374138,0.002922687,0.0001326181,0.001258547,0.03914685],"study_design_scores_gemma":[0.8260297,0.1564941,0.00982473,0.0001253192,0.003082733,0.00007886322,0.00008588676,0.001135553,0.001202249,0.0003171469,0.001590327,0.00003350536],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889486,0.006776378,0.0002888385,0.0004727839,0.0002722199,0.0005061699,0.0007930619,0.00008423246,0.00185775],"genre_scores_gemma":[0.9904976,0.003599646,0.0006122333,0.0008661009,0.000193577,0.0006021116,0.001142109,0.00002946173,0.002457073],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004342972,"threshold_uncertainty_score":0.01452869,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02955306056634085,"score_gpt":0.4112518398412691,"score_spread":0.3816987792749282,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}